Literature DB >> 26260762

Bone: Targeting myostatin could prevent bone destruction in inflammatory arthritis.

Sarah Onuora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26260762     DOI： 10.1038/nrrheum.2015.113

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.

Authors:  Berno Dankbar; Michelle Fennen; Daniela Brunert; Silvia Hayer; Svetlana Frank; Corinna Wehmeyer; Denise Beckmann; Peter Paruzel; Jessica Bertrand; Kurt Redlich; Christina Koers-Wunrau; Athanasios Stratis; Adelheid Korb-Pap; Thomas Pap
Journal:  Nat Med       Date:  2015-08-03       Impact factor: 53.440
  1 in total
  2 in total

Review 1.  Organokines in Rheumatoid Arthritis: A Critical Review.

Authors:  Lucas Fornari Laurindo; Mariana Canevari de Maio; Sandra Maria Barbalho; Elen Landgraf Guiguer; Adriano Cressoni Araújo; Ricardo de Alvares Goulart; Uri Adrian Prync Flato; Edgar Baldi Júnior; Cláudia Rucco Penteado Detregiachi; Jesselina Francisco Dos Santos Haber; Patrícia C Santos Bueno; Raul S J Girio; Rachel Gomes Eleutério; Marcelo Dib Bechara
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

2.  Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis.

Authors:  Jianmin Xie; Hao Wang
Journal:  Arthritis Res Ther       Date:  2017-01-21       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.